# Longevity Venture Partners

Longevity Venture Partners is a Venture Capital based in Pikesville, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Pikesville, United States
- **Region:** North America
- **Address:** Baltimore, MD, United States
- **Founded:** 2020
- **Assets under management:** Undisclosed
- **Website:** longevityventurepartners.com
- **LinkedIn:** linkedin.com/company/longevity-venture-partners

## Regulatory record

- **CRD number:** 326760
- **SEC file number:** 802-132713
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/326760

## About

Longevity Venture Partners is an American early-stage venture capital fund specializing in the Silvertech, Healthcare and Wellness sectors. CommuniCare Family of Companies is Longevity’s parent company and a major U.S. health care enterprise with more than 90 facilities in the U.S.

## Sectors

- Digital Health
- AI/ML
- Enterprise Software
- Healthcare Services

## Questions

### What is Longevity Venture Partners' core investment thesis?

The firm concentrates exclusively on extending healthy human lifespan through early-stage venture investments. Its thesis targets the biology of aging across therapeutic development, diagnostic platforms, and AI-enabled drug discovery. This pure-play approach means it does not diversify into general biotech or healthtech sectors outside the longevity umbrella.

### Does Longevity Venture Partners lead rounds or participate as a co-investor?

The firm's participation posture is not publicly confirmed. Early-stage longevity vehicles of similar size often prefer co-investment or syndicate participation alongside larger biotech funds. Without direct disclosure, the firm's lead-investor appetite remains unverified.

### Which sectors does Longevity Venture Partners explicitly avoid?

By structural design, the firm avoids any sector outside the longevity economy. This excludes general biotechnology, medical devices not directly tied to aging mechanisms, late-stage pharmaceuticals, and health IT platforms without a geroscience or lifespan-extension component.

## Related profiles

- [Longevity Tech Fund](https://altss.com/profile/longevity-tech-fund)
- [Longevity Vision Holding](https://altss.com/profile/longevity-vision-holding)

---

Last updated: 2026-08-11T15:07:19.634Z

Canonical page: https://altss.com/profile/longevity-venture-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology